Annovis Sets Investor Webinar as Neurodegeneration Pipeline Reaches Inflection
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) said it will host a corporate update webinar later this month as the clinical-stage biotechnology company moves into what it describes as …
Annovis Sets Investor Webinar as Neurodegeneration Pipeline Reaches Inflection Read More